Amgen to Hold Conference Call Today after the Close of Financial Markets Read more about Amgen to Hold Conference Call Today after the Close of Financial Markets
First Year Amgen Scholars and Leading Scientists Attend Symposium to Explore Drug Discovery & Development Read more about First Year Amgen Scholars and Leading Scientists Attend Symposium to Explore Drug Discovery & Development
Dennis Fenton, Executive Vice President of Operations, Elects to Retire after 25 Years with Amgen Read more about Dennis Fenton, Executive Vice President of Operations, Elects to Retire after 25 Years with Amgen
Amgen Responds to Final CMS National Coverage Determination on Use of Erythropoiesis-Stimulating Agents in Oncology Read more about Amgen Responds to Final CMS National Coverage Determination on Use of Erythropoiesis-Stimulating Agents in Oncology
Amgen's Second Quarter 2007 Adjusted Earnings Per Share Increased 7 Percent to $1.12 Read more about Amgen's Second Quarter 2007 Adjusted Earnings Per Share Increased 7 Percent to $1.12
On an Adjusted Basis, Amgen Reports Fourth Quarter Earnings Per Share Increase 17 Percent to 35 Cents, Full Year 2002 Increase 18 Percent to $1.39 Read more about On an Adjusted Basis, Amgen Reports Fourth Quarter Earnings Per Share Increase 17 Percent to 35 Cents, Full Year 2002 Increase 18 Percent to $1.39
Amgen Submits Testimony to House Ways & Means Committee Read more about Amgen Submits Testimony to House Ways & Means Committee
Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program Read more about Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
